SIRO Clinpharm appoints chief executive

Takes responsibility for expanding business across the US, Europe and Asia

SIRO Clinpharm, a clinical research organisation headquartered in Mumbai, India has appointed Gopakumar Menon as chief executive to build and enhance the firm’s biopharma service offering, across the US, Europe and Asia.

Menon has been working in the pharmaceutical industry for the more than 12 years in various capacities, from discovery to sales and marketing.

Prior to joining SIRO Clinpharm he worked for Boston, US-based Sciformix. He has had significant experience working with Fortune 500 companies such as Cognizant and Satyam, as well as with venture funded start-up organisations.

SIRO Clinpharm has offices in India, Malaysia, US, Israel Germany, Romania, Estonia, Greece, Czech Republic and Spain.

You may also like

Regulatory

SIRO Clinpharm expands its presence in Asia

Launches operations in Malaysia
Regulatory

SIRO Clinpharm seeks Asia Pacific growth with DreamCIS pact

Mumbai-based contract research organisation SIRO Clinpharm has formed an alliance with DreamCIS, a CRO based in Seoul, South Korea in order to build its business in the Asia Pacific region.
Research & Development

From lab to launch: transforming pharmaceutical formulation development with GEA’s CFC Lab Coater

A new generation of continuous film coating technology is giving R&D teams the speed, precision and scalability they need to take products from the laboratory to commercial production without the traditional bottlenecks
Manufacturing

Bristol Myers Squibb licenses Lonza ADC linker-payload technology for undisclosed target

BMS has secured exclusive access to Lonza’s SYNtecan linker-payload platform, alongside GlycoConnect and HydraSpace technologies, to advance development of an antibody-drug conjugate against an undisclosed target
Drug Delivery

Neuland Laboratories to partner with LIR Life Sciences for transdermal GLP-1 development

The pair will work to advance LIR Life's novel cell-penetrating peptides for next-generation obesity therapies, looking to improve patient adherence and broaden access
Hi Tech Manufacturing

Hongene to support SiranBio siRNA candidate programme with CDMO services

The RNA specialist will support SiranBio's SA1211 programme, helping advance the siRNA candidate through its vertically integrated CDMO services to address the complex nature of the next-gen therapeutic
Research & Development

Reacta Healthcare announces expansion into Asia-Pacific and appoints Professor Gary Wing-Kin Wong to advisory board

Reacta Healthcare, a leading developer and manufacturer of pharmaceutical-grade oral food challenge (OFC) products for food allergy diagnostics, today announces the appointment of Professor Gary Wing-Kin Wong, internationally recognised paediatric allergy and respiratory disease expert and President-Elect of the World Allergy Organisation (WAO), to its Advisory Board, as the company accelerates new product development and expands its Asia-Pacific (APAC) footprint
Subscribe now